Found 65 matching trials
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion PHASE4 A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions N/A Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Show More Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Learn More & Join Trial
Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification PHASE2 The goal of this clinical trial is to learn if the combination of lenvatini...
Show More Learn More & Join Trial
Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer PHASE2 This is an open-label, multi-center Phase II study of cadonilimab (AK104) c...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Cetntre
Learn More & Join Trial
HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma N/A Intrahepatic cholangiocarcinoma (ICC) is associated with poor prognosis. Th...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC N/A Vessels that encapsulate tumor clusters (VETC) is an invasive metastatic fa...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Learn More & Join Trial
TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma N/A Although the combination of transarterial chemoembolization (TACE) with PD-...
Show More Location
Multiple Locations
Learn More & Join Trial
Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO) PHASE2 The PLUTO-trial is a single-center, open-label, phase II trial investigatin...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Learn More & Join Trial
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) N/A The purpose of this study is to evaluate the safety and efficacy of hepatic...
Show More Location
The first hospital of China medical university
Learn More & Join Trial
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging N/A The goal of this observational study is to learn about the long-term treatm...
Show More Status
Active Not Recruiting
Location
The First Affiiated Hospital of Sun Yat-sen University
Learn More & Join Trial